NGS-based tumor genomic profiling to identify ovarian cancer patients who benefit from the PARP inhibitor rucaparib Meeting Abstract
| Authors: | McNeish, I. A.; Lin, K. K.; Sun, J. X.; Goble, S.; Oza, A.; Coleman, R. L.; Scott, C. L.; Konecny, G.; Tinker, A. V.; O'Malley, D. M.; Kristeleit, R.; Ma, L.; Brenton, J. D.; Bell-McGuinn, K.; Oaknin, A.; Leary, A.; Mann, E.; Giordano, H.; Yelensky, R.; Raponi, M.; Swisher, E. |
| Abstract Title: | NGS-based tumor genomic profiling to identify ovarian cancer patients who benefit from the PARP inhibitor rucaparib |
| Meeting Title: | American Association for Cancer Research (AACR) Special Conference on the Advances in Ovarian Cancer Research: Exploiting Vulnerabilities |
| Journal Title: | Clinical Cancer Research |
| Volume: | 22 |
| Issue: | 2 Suppl. |
| Meeting Dates: | 2015 Oct 17-20 |
| Meeting Location: | Orlando, FL |
| ISSN: | 1078-0432 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2016-01-15 |
| Language: | English |
| ACCESSION: | WOS:000373342300010 |
| PROVIDER: | wos |
| DOI: | 10.1158/1557-3265.OVCA15-A11 |
| Notes: | Meeting Abstract: A11 -- Source: Wos |
